Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BENSERAZIDE\LEVODOPA Cause Parkinson's disease? 126 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Parkinson's disease have been filed in association with BENSERAZIDE\LEVODOPA. This represents 6.2% of all adverse event reports for BENSERAZIDE\LEVODOPA.

126
Reports of Parkinson's disease with BENSERAZIDE\LEVODOPA
6.2%
of all BENSERAZIDE\LEVODOPA reports
11
Deaths
32
Hospitalizations

How Dangerous Is Parkinson's disease From BENSERAZIDE\LEVODOPA?

Of the 126 reports, 11 (8.7%) resulted in death, 32 (25.4%) required hospitalization.

Is Parkinson's disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BENSERAZIDE\LEVODOPA. However, 126 reports have been filed with the FAERS database.

What Other Side Effects Does BENSERAZIDE\LEVODOPA Cause?

Fall (282) Dizziness (151) Hallucination (136) Dyskinesia (127) General physical health deterioration (127) Drug ineffective (119) Confusional state (117) Off label use (112) Somnolence (110) Hypotension (105)

What Other Drugs Cause Parkinson's disease?

CARBIDOPA\LEVODOPA (3,140) PIMAVANSERIN (1,918) LEVODOPA (761) ROTIGOTINE (419) CARBIDOPA\ENTACAPONE\LEVODOPA (361) CLOZAPINE (335) RIVASTIGMINE (284) ADALIMUMAB (277) APIXABAN (264) QUETIAPINE (248)

Which BENSERAZIDE\LEVODOPA Alternatives Have Lower Parkinson's disease Risk?

BENSERAZIDE\LEVODOPA vs BENZALKONIUM BENSERAZIDE\LEVODOPA vs BENZOCAINE BENSERAZIDE\LEVODOPA vs BENZODIAZEPINE BENSERAZIDE\LEVODOPA vs BENZONATATE BENSERAZIDE\LEVODOPA vs BENZOYL PEROXIDE

Related Pages

BENSERAZIDE\LEVODOPA Full Profile All Parkinson's disease Reports All Drugs Causing Parkinson's disease BENSERAZIDE\LEVODOPA Demographics